ArticleOpen medicine (Warsaw, Poland)2021

Retraction on "Dihydromyricetin attenuates inflammation through TLR4/NF-kappa B pathway".

Nianshui Jing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.